NFE2L2 and metabolic dysfunction-associated steatotic liver disease: In the present study, we demonstrated for the first time that ECH delayed the development of MASLD by inhibiting ferroptosis and protecting mitochondrial function in hepatocytes through increasing the activity of Nrf2.